505 related articles for article (PubMed ID: 35505025)
21. Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets.
Hsieh YJ; Wu CC; Chang CJ; Yu JS
J Cell Physiol; 2003 Mar; 194(3):363-75. PubMed ID: 12548556
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy (PDT) - Initiation of apoptosis via activation of stress-activated p38 MAPK and JNK signal pathway in H460 cell lines.
Wu RW; Yow CM; Wong CK; Lam YH
Photodiagnosis Photodyn Ther; 2011 Sep; 8(3):254-63. PubMed ID: 21864799
[TBL] [Abstract][Full Text] [Related]
23. Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells.
Weijer R; Broekgaarden M; van Golen RF; Bulle E; Nieuwenhuis E; Jongejan A; Moerland PD; van Kampen AH; van Gulik TM; Heger M
BMC Cancer; 2015 Dec; 15():1014. PubMed ID: 26705830
[TBL] [Abstract][Full Text] [Related]
24. Development of resistance to photodynamic therapy (PDT) in human breast cancer cells is photosensitizer-dependent: Possible mechanisms and approaches for overcoming PDT-resistance.
Olsen CE; Weyergang A; Edwards VT; Berg K; Brech A; Weisheit S; Høgset A; Selbo PK
Biochem Pharmacol; 2017 Nov; 144():63-77. PubMed ID: 28784290
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of the Effect of Methyl Pyropheophorbide-a-Mediated Photodynamic Therapy was Achieved by Increasing ROS through Inhibition of Nrf2-HO-1 or Nrf2-ABCG2 Signaling.
Tian S; Yong M; Zhu J; Zhang L; Pan L; Chen Q; Li KT; Kong YH; Jiang Y; Yu TH; Yu LH; Bai DQ
Anticancer Agents Med Chem; 2017; 17(13):1824-1836. PubMed ID: 28356018
[TBL] [Abstract][Full Text] [Related]
26. Low-dose photodynamic therapy promotes angiogenic potential and increases immunogenicity of human mesenchymal stromal cells.
Udartseva OO; Zhidkova OV; Ezdakova MI; Ogneva IV; Andreeva ER; Buravkova LB; Gollnick SO
J Photochem Photobiol B; 2019 Oct; 199():111596. PubMed ID: 31450129
[TBL] [Abstract][Full Text] [Related]
27. Emerging Therapeutic Targets in Oncologic Photodynamic Therapy.
Manda G; Hinescu ME; Neagoe IV; Ferreira LFV; Boscencu R; Vasos P; Basaga SH; Cuadrado A
Curr Pharm Des; 2018; 24(44):5268-5295. PubMed ID: 30674246
[TBL] [Abstract][Full Text] [Related]
28. [Photodynamic therapy – significance in oncology].
Mossakowska B; Fabisiewicz A; Siedlecki J
Postepy Biochem; 2021 Sep; 67(3):236-247. PubMed ID: 34894388
[TBL] [Abstract][Full Text] [Related]
29. Broaden sources and reduce expenditure: Tumor-specific transformable oxidative stress nanoamplifier enabling economized photodynamic therapy for reinforced oxidation therapy.
Xu X; Huang B; Zeng Z; Chen J; Huang Z; Guan Z; Chen M; Huang Y; Zhao C
Theranostics; 2020; 10(23):10513-10530. PubMed ID: 32929363
[TBL] [Abstract][Full Text] [Related]
30. Photodynamic therapy using pheophorbide and 670nm LEDs exhibits anti-cancer effects in-vitro in androgen dependent prostate cancer.
Gheewala T; Skwor T; Munirathinam G
Photodiagnosis Photodyn Ther; 2018 Mar; 21():130-137. PubMed ID: 29102652
[TBL] [Abstract][Full Text] [Related]
31. Anti-apoptotic effects of curcumin on photosensitized human epidermal carcinoma A431 cells.
Chan WH; Wu HJ
J Cell Biochem; 2004 May; 92(1):200-12. PubMed ID: 15095415
[TBL] [Abstract][Full Text] [Related]
32. Promotion of photodynamic therapy-induced apoptosis by stress kinases.
Xue Ly; He J; Oleinick NL
Cell Death Differ; 1999 Sep; 6(9):855-64. PubMed ID: 10510467
[TBL] [Abstract][Full Text] [Related]
33. High efficiency of 5-aminolevulinate-photodynamic treatment using UVA irradiation.
Buchczyk DP; Klotz LO; Lang K; Fritsch C; Sies H
Carcinogenesis; 2001 Jun; 22(6):879-83. PubMed ID: 11375893
[TBL] [Abstract][Full Text] [Related]
34. New insights into the mechanisms for photodynamic therapy-induced cancer cell death.
Yoo JO; Ha KS
Int Rev Cell Mol Biol; 2012; 295():139-74. PubMed ID: 22449489
[TBL] [Abstract][Full Text] [Related]
35. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
[TBL] [Abstract][Full Text] [Related]
36. A Review of Chemotherapy and Photodynamic Therapy for Lung Cancer Treatment.
El-Hussein A; Manoto SL; Ombinda-Lemboumba S; Alrowaili ZA; Mthunzi-Kufa P
Anticancer Agents Med Chem; 2021; 21(2):149-161. PubMed ID: 32242788
[TBL] [Abstract][Full Text] [Related]
37. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells.
Buytaert E; Matroule JY; Durinck S; Close P; Kocanova S; Vandenheede JR; de Witte PA; Piette J; Agostinis P
Oncogene; 2008 Mar; 27(13):1916-29. PubMed ID: 17952126
[TBL] [Abstract][Full Text] [Related]
38. Cellular changes, molecular pathways and the immune system following photodynamic treatment.
Skupin-Mrugalska P; Sobotta L; Kucinska M; Murias M; Mielcarek J; Düzgüneş N
Curr Med Chem; 2014; 21(35):4059-73. PubMed ID: 25174920
[TBL] [Abstract][Full Text] [Related]
39. 9-Hydroxypheophorbide α-mediated photodynamic therapy induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in Hep-2 cells via ROS-mediated suppression of the ERK pathway.
Zhang H; Shen B; Swinarska JT; Li W; Xiao K; He P
Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):55-62. PubMed ID: 24448387
[TBL] [Abstract][Full Text] [Related]
40. Molecular response to hypericin-induced photodamage.
Krammer B; Verwanger T
Curr Med Chem; 2012; 19(6):793-8. PubMed ID: 22214453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
